Table 4 Relationship between dose of SU and hypoglycemia.

From: Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring

  High dose
SU group (n = 10)
Recommended dose
SU group (n = 53)
non-SU group
(n = 60)
P
Presence of TBR < 70, n (%) 3 (30.0) 7 (13.2) 7 (11.7) 0.265
Presence of TBR < 54, n (%) 2 (20.0) 2 (3.77) 0 (0) 0.008*
  1. We showed the number of patients who presence of TBR < 70 and < 54. We used Fisher’s exact test. *p < 0.05.